Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Plo

Showing results (31-40 of 124) with videos related to

Pageof 13
Sort By:
Faculty Reviews|September 29, 2023
Recent advances in therapies for primary myelofibrosisWilliam Vainchenker, Nasrine Yahmi, Violaine Havelange, et al.
F1000Research|February 6, 2018
JAK inhibitors for the treatment of myeloproliferative neoplasms and other disordersWilliam Vainchenker, Emilie Leroy, Laure Gilles, et al.
Molecular Pharmacology|July 20, 2002
Influence of ceramide metabolism on P-glycoprotein function in immature acute myeloid leukemia KG1a cellsIsabelle Plo, Gustav Lehne, Karen Johanne Beckstrøm, et al.
Journal of Experimental Therapeutics & Oncology|May 3, 2003
Phosphatidylcholine-derived phosphatidic acid and diacylglycerol are involved in the signaling pathways activated by docetaxelNicolas Maestre, Christine Bezombes, Isabelle Plo, et al.
Blood Reviews|June 14, 2020
Germline genetic factors in the pathogenesis of myeloproliferative neoplasmsChristine Bellanné-Chantelot, Graciela Rabadan Moraes, Barbara Schmaltz-Panneau, et al.
DNA Repair|September 19, 2003
Association of XRCC1 and tyrosyl DNA phosphodiesterase (Tdp1) for the repair of topoisomerase I-mediated DNA lesionsIsabelle Plo, Zhi Yong Liao, Juana M Barceló, et al.
Blood|August 1, 2002
Kit signaling inhibits the sphingomyelin-ceramide pathway through PLC gamma 1: implication in stem cell factor radioprotective effectStéphane Maddens, Alexandra Charruyer, Isabelle Plo, et al.
The Journal of Biological Chemistry|January 25, 2013
BRCA1-Ku80 protein interaction enhances end-joining fidelity of chromosomal double-strand breaks in the G1 phase of the cell cycleGuochun Jiang, Isabelle Plo, Tong Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
Emergence of a BCR-ABL translocation in a patient with the JAK2V617F mutation: evidence for secondary acquisition of BCR-ABL in the JAK2V617F cloneOsamu Yamada, Emna Mahfoudhi, Isabelle Plo, et al.
Blood|June 3, 2008
JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disordersIsabelle Plo, Mayuka Nakatake, Laurent Malivert, et al.
Pageof 13

Showing results (31-40 of 124) with videos related to

Sort By:
Pageof 13
Faculty Reviews|September 29, 2023
Recent advances in therapies for primary myelofibrosisWilliam Vainchenker, Nasrine Yahmi, Violaine Havelange, et al.
F1000Research|February 6, 2018
JAK inhibitors for the treatment of myeloproliferative neoplasms and other disordersWilliam Vainchenker, Emilie Leroy, Laure Gilles, et al.
Molecular Pharmacology|July 20, 2002
Influence of ceramide metabolism on P-glycoprotein function in immature acute myeloid leukemia KG1a cellsIsabelle Plo, Gustav Lehne, Karen Johanne Beckstrøm, et al.
Journal of Experimental Therapeutics & Oncology|May 3, 2003
Phosphatidylcholine-derived phosphatidic acid and diacylglycerol are involved in the signaling pathways activated by docetaxelNicolas Maestre, Christine Bezombes, Isabelle Plo, et al.
Blood Reviews|June 14, 2020
Germline genetic factors in the pathogenesis of myeloproliferative neoplasmsChristine Bellanné-Chantelot, Graciela Rabadan Moraes, Barbara Schmaltz-Panneau, et al.
DNA Repair|September 19, 2003
Association of XRCC1 and tyrosyl DNA phosphodiesterase (Tdp1) for the repair of topoisomerase I-mediated DNA lesionsIsabelle Plo, Zhi Yong Liao, Juana M Barceló, et al.
Blood|August 1, 2002
Kit signaling inhibits the sphingomyelin-ceramide pathway through PLC gamma 1: implication in stem cell factor radioprotective effectStéphane Maddens, Alexandra Charruyer, Isabelle Plo, et al.
The Journal of Biological Chemistry|January 25, 2013
BRCA1-Ku80 protein interaction enhances end-joining fidelity of chromosomal double-strand breaks in the G1 phase of the cell cycleGuochun Jiang, Isabelle Plo, Tong Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
Emergence of a BCR-ABL translocation in a patient with the JAK2V617F mutation: evidence for secondary acquisition of BCR-ABL in the JAK2V617F cloneOsamu Yamada, Emna Mahfoudhi, Isabelle Plo, et al.
Blood|June 3, 2008
JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disordersIsabelle Plo, Mayuka Nakatake, Laurent Malivert, et al.
Pageof 13